Mira Pharmaceuticals (MIRA) Payables (2022 - 2025)

Mira Pharmaceuticals (MIRA) posted Payables of $129203.0 for Q4 2025, up 53.95% sequentially from $83926.0 in Q3 2025, and down 82.14% YoY from $723349.0 in Q4 2024.

Mira Pharmaceuticals (MIRA) Payables (2022 - 2025) Analysis & Trends

Mira Pharmaceuticals (MIRA) has 4 years of Payables data on file, last reported at $129203.0 in Q4 2025.

  • Quarterly Payables fell 82.14% year-over-year to $129203.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $129203.0 (down 82.14% YoY) and the FY2025 annual result came in at $129203.0, down 82.14% from the prior year.
  • Payables grew to $129203.0 in Q4 2025 per MIRA's latest filing, from $83926.0 in the prior quarter.
  • The five-year high for Payables was $811738.0 in Q4 2022, with the low at $83926.0 in Q3 2025.
  • Average Payables over 4 years is $494520.2, with a median of $636261.0 recorded in 2024.
  • Year-over-year, Payables soared 34.31% in 2024 and tumbled 87.89% in 2025.
  • Mira Pharmaceuticals' Payables stood at $811738.0 in 2022, then tumbled by 33.65% to $538564.0 in 2023, then surged by 34.31% to $723349.0 in 2024, then plunged by 82.14% to $129203.0 in 2025.
  • Business Quant data shows MIRA's Payables at $129203.0 in Q4 2025, $83926.0 in Q3 2025, and $298459.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 5.03 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 27.92 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 33.77 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -22.55 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 6.01 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 2.94 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 645.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 4.51 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Mira Pharmaceuticals 22.51 Mn 11.48 Mn - 129,203.00

Historic Data

Download Data
DateValue
Dec 31, 2025 129,203.00
Sep 30, 2025 83,926.00
Jun 30, 2025 298,459.00
Mar 31, 2025 100,673.00
Dec 31, 2024 723,349.00
Sep 30, 2024 692,833.00
Mar 31, 2024 636,261.00
Dec 31, 2023 538,564.00
Sep 30, 2023 779,573.00
Jun 30, 2023 645,143.00
Dec 31, 2022 811,738.00